glp 1 news A GLP-1 insurance change is impacting millions of Americans. Here's what you need to know about Medicare's new GLP-1 Bridge program: https://fox59.com/news/national-world/glp-1-insurance-change-impacts-millions-of-americans-what-to-know-how-to-tell-if Fmr. FDA Commissioner weighs in

One major study called the FLOW trial found that GLP-1 medications reduced kidney problems by 24 percent in people with diabetes

However, the authors urge caution in interpreting these findings due to the limited number of trials, the variations in study designs, and the heterogeneity in patient populations and substance types studied

Treating the mice with a GLP-1 receptor agonist did not slow their gastric emptying

adults reported taking GLP-1RAs for weight loss, diabetes, or another chronic condition, according to a November 2025 KFF Health Track poll

The other senior author is Markus Stoffel, MD, PhD, professor of metabolic diseases at the Institute of Molecular Health Sciences, ETH Zurich in Switzerland

GLP-1 receptor agonists are primarily used to treat type 2 diabetes by lowering blood sugar and reducing food intake